The OCEANIC-AF trial randomized patients to either the novel factor XIa inhibitor asundexian 50 mg once daily or apixaban 5 mg or 2.5 mg twice daily. The trial was terminated early because asundexian ...

【新读】谷歌Deep Research重大升级，搭载全球顶尖Gemini 2.5 Pro模型。5分钟生成46页学术论文、复杂报告转为10分钟播客。性能超OpenAI DR 40%，价格仅为其1/10 ...

With GenAI tools getting immersive and impressive by the day, let’s look at two popular ones – Google’s Gemini 2.5 Pro and OpenAI’s ChatGPT (powered by GPT-4). Both are highly capable.

The Terron 9 and U9 will be sold here with a turbo-diesel 2.5-litre four-cylinder engine producing 164kW of power. While neither LDV Australia nor MG Australia have published a torque figure, SAIC ...

Google said Gemini 2.5 Pro will soon be rolled out to Vertex AI The tech giant will charge higher prices after using 2,00,000 tokens Gemini 2.5 Pro is also available to users via Gemini Advanced ...

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of ...

Google has just released its latest voice model, Gemini 2.5 Pro, for free users. The new model, which is still in an 'experimental' phase, can be selected from the drop-down menu on the Gemini ...

Participants were randomized to oral apixaban at a reduced dose (2.5 mg) or a full dose (5.0 mg) twice daily for 12 months. The primary outcome was centrally adjudicated fatal or nonfatal ...

Earlier this week, Google unveiled Gemini 2.5, the company’s most advanced AI model to date, with integrated thinking capabilities. It is capable of analyzing complex information with contextual ...

Last yesterday evening, Google announced that its latest Gemini 2.5 Pro model is now available to all users. The latest version of Gemini is available in an experimental state, and you can try it ...

Google Gemini has rolled out its powerful new 2.5 Pro experimental model to non-paying users, just days after its arrival on Gemini Advanced. Despite being available to free users, there will be ...

CHICAGO, IL—For patients with active cancer who’ve had venous thromboembolism (VTE), 12-month extended anticoagulation with reduced-dose apixaban is noninferior to the full dose at preventing ...